Genel
'I have no preexisting conditions': I'm 56, earn $198,000 and want to retire early. Can I afford private healthcare?
...
Read More
Genel
Daraxonrasib vs. pancreatic cancer: Experimental pill helped people live longer
New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's effects eventually waned....
Read More
Genel
Ivonescimab with Chemotherapy Demonstrated a Statistically Significant Overall Survival Benefit Compared to Tislelizumab Plus Chemotherapy in 1L Treatment of Patients with Squamous NSCLC in the HARMONi-6 Study Conducted by Akeso in China
...
Read More
Genel
HARMONi-6 Demonstrates Significant Overall Survival Benefit (HR=0.66): Ivonescimab Plus Chemotherapy Superior to PD-1 Plus Chemotherapy in First-Line sq-NSCLC Landmark Results to Be Presented at ASCO 2026 Plenary Session
...
Read More
Genel
Game 7: Spurs at Thunder to decide Western Conference crown
For the 160th time in NBA history and fifth time this season alone, a Game 7 awaits on Saturday night....
Read More
Genel
Women's FA Cup final LIVE: Brighton & Hove Albion vs Manchester City - score, radio commentary, text updates & match stats
Listen to BBC Radio 5 Live commentary and follow live text coverage as Brighton & Hove Albion take on Manchester City in the Women's FA Cup final....
Read More
Genel
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
...
Read More
Genel
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) pivotal data show strong and durable responses in advanced head and neck cancer where options remain limited
...
Read More
Genel
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
...
Read More1
2
3
4
5
6
7
8
9
10
